APA (7th ed.) Citation

J, S., J, X., X, W., SM, J., BE, B., JS, M., . . . HJ, Z. (2022). Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism. Clinical pharmacology and therapeutics, 111(4), 878. https://doi.org/10.1002/cpt.2486

Chicago Style (17th ed.) Citation

J, Shi, Xiao J, Wang X, Jung SM, Bleske BE, Markowitz JS, Patrick KS, and Zhu HJ. "Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism." Clinical Pharmacology and Therapeutics 111, no. 4 (2022): 878. https://doi.org/10.1002/cpt.2486.

MLA (9th ed.) Citation

J, Shi, et al. "Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism." Clinical Pharmacology and Therapeutics, vol. 111, no. 4, 2022, p. 878, https://doi.org/10.1002/cpt.2486.